Dr Nick N Gorgani
Inventor, Founder & CEO - Sydney, Australia and San Diego, USA
Dr Gorgani (BE, MBBS, MS Drug Dev, PhD), is the inventor of this technology and the
founder and CEO of OzStar Therapeutics. He has gained multidisciplinary training spanning
from chemical engineering to medicine to immunology and to industrial drug development.
He has worked for academic institutions, hospitals and biotechnology/pharmaceutical
companies. Dr Gorgani has led numerous classes of patentable discoveries including, non-
inflammatory disposal of pathogens and dying cells, the discovery of a new biologic for the
treatment of RA and AMD, the discovery of mechanism of action of a small molecule that
mediates immune tolerance, the discovery of a world first-in-class small molecule for the
treatment of proteinuria, and the discovery of a new therapy for the treatment of type 2
Dr Gorgani has received numerous awards including Turkish Ministry of Health and
Government scholarships, Australian National University PhD Scholarship, United States
Arthritis Foundation Postdoctoral Fellowship, Scripps Research Institute Society of Fellows
Excellence in Research Award and two grants from the Australian Government. He is a
clinical senior lecturer in the School of Paediatrics and Reproductive Health, University of
Adelaide and at the Department of Medicine, University of Sydney. He has trained a number
of students and postdoctoral fellows and examined a number of PhD and Master’s degree
thesis and peer-reviewed manuscripts for world-leading scientific journals.
Karl HS Kim
Principal Medical Expert - San Diego, USA
Dr Kim (MD, PhD) serves as principal medical expert of OzStar Therapeutics. Dr. Kim is a
physician-scientist with a unique combination of knowledge, perspectives and experiences
across small biopharma, medium and large pharmaceuticals covering the entire clinical
development aspects including early and late phases (comprising IND, Phases I, II, III, NDA
and product launch activity support) and life-cycle management / post-marketing safety
survey, including Phase IV studies in multiple therapeutic areas at Avanir Pharmaceuticals,
Santarus Pharmaceuticals, Theravance, Bayer HealthCare, and Berlex/Shering AG. Dr. Kim’
s diverse educational backgrounds include B.S. in Electrical Engineering with Biomedical
Engineering Option from Michigan State University, Ph.D. in Neuroscience from Cornell
Graduate School of Medical Sciences / Sloan-Kettering Institute, M.D. from Cornell University
Medical College with Radiology training at Albert Einstein College of Medicine, and Clinical
Pharmacology Research Fellowship at Georgetown University Medical Center.
Dr Kim is leading the clinical safety and trial operations for OzStar's phase 2a clinical trial.
Ms Mahnoosh Afkham
Chief Quality Control Officer - San Diego, United States
Ms. Mahnoosh Afkham (BSc, MSc) is a Chief Quality Control Officer of OzStar Therapeutics.
She has over 20 years of experience in diagnostics and biotechnology with US based
companies such as Gen-Probe and Genentech/Roche. In Australia, Mahnoosh has
contributed to biotechnology and pharmaceutical companies such as Hospira, Adelaide and
Sigma Pharmaceuticals, Sydney and gained experience and expertise in method validation
and analytical method development for quality control of GMP manufactured products.
Mahnoosh has a BSc in Chemistry and an MSc in Analytical Chemistry from San Diego State
Mahnoosh is leading the quality assurance aspects of OzStar products.
Ms Wendy Free
Chief Regulatory Officer - Brisbane, Australia
Ms Free (BSc, M. Tech Management, MASM, MRACI, FAOQ) is OzStar’s Chief Regulatory
Affairs Officer, with specific responsibility for regulatory matters, cGMP manufacture and
drug development. Ms Free has extensive local and international experience in facilitating
the successful transition to the marketplace of a wide range of medicaments and allied
technologies. Ms Free provides consulting advice to a range of organisations including
private, public and government. She is the Managing Director of Quality Matters Safety
Matters Pty Ltd, lectures at University of Queensland, is a mentor for Commercialisation
Australia, and an APVMA GMP auditor.
Ms Free is leading the regulatory aspects of OzStar’s product development.